Despite continuing challenges brought about by the prolonged pandemic, the year 2021 marked a turning point for Boustead. After six consecutive quarters of losses, we started recording a profit after tax (PAT) from the first quarter onwards and ended 2021 with a full-year PAT of RM479 million, making it our first full profitable year since 2018.
While our performance was greatly boosted by the increase in price of commodities and demand for healthcare, all our Divisions performed well, especially our Pharmaceutical, Plantation and Trading, Finance & Investment. At the same time, there has also been a reinvigoration of spirit throughout the Group which is driving all the companies within our fold to achieve operational excellence and to optimise profit while generating sustainable value. Thanks to Reinventing Boustead, we are today more digitally-driven, efficient and relevant. More importantly, we operate by upholding a higher level of professionalism and integrity.